Preferred Label : (131)I-ch81C6;
MeSH note : human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled
with 131I and administered into the surgically created resection cavity of patients
with malignant glioma, in phase I trial (6/2006);
Is substance : O;
Origin ID : C511833;
UMLS CUI : C1723325;
MeSH term(s) associated for indexing
Record concept(s)
Semantic type(s)